Stille AB manufactures and distributes medical devices. Its products include surgical equipment such as Surgical Scissors, Forceps, Curettes, Raspatories, Elevators, c-arm tables and instrument care education, among others.
1841
147
LTM Revenue $61.0M
LTM EBITDA $12.1M
$185M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Stille has a last 12-month revenue (LTM) of $61.0M and a last 12-month EBITDA of $12.1M.
In the most recent fiscal year, Stille achieved revenue of $60.2M and an EBITDA of $12.6M.
Stille expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See Stille valuation multiples based on analyst estimatesLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Revenue | $61.0M | XXX | $60.2M | XXX | XXX | XXX |
Gross Profit | $31.5M | XXX | $31.2M | XXX | XXX | XXX |
Gross Margin | 52% | XXX | 52% | XXX | XXX | XXX |
EBITDA | $12.1M | XXX | $12.6M | XXX | XXX | XXX |
EBITDA Margin | 20% | XXX | 21% | XXX | XXX | XXX |
EBIT | $8.9M | XXX | $12.1M | XXX | XXX | XXX |
EBIT Margin | 15% | XXX | 20% | XXX | XXX | XXX |
Net Profit | $7.2M | XXX | $6.1M | XXX | XXX | XXX |
Net Margin | 12% | XXX | 10% | XXX | XXX | XXX |
Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of July 3, 2025, Stille's stock price is SEK 206 (or $22).
Stille has current market cap of SEK 1.9B (or $195M), and EV of SEK 1.8B (or $185M).
See Stille trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$185M | $195M | XXX | XXX | XXX | XXX | $0.80 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of July 3, 2025, Stille has market cap of $195M and EV of $185M.
Stille's trades at 3.1x EV/Revenue multiple, and 14.8x EV/EBITDA.
Equity research analysts estimate Stille's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Stille has a P/E ratio of 27.1x.
See valuation multiples for Stille and 12K+ public compsLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Market cap (current) | $195M | XXX | $195M | XXX | XXX | XXX |
EV (current) | $185M | XXX | $185M | XXX | XXX | XXX |
EV/Revenue | 3.0x | XXX | 3.1x | XXX | XXX | XXX |
EV/EBITDA | 15.4x | XXX | 14.8x | XXX | XXX | XXX |
EV/EBIT | 20.9x | XXX | 15.3x | XXX | XXX | XXX |
EV/Gross Profit | 5.9x | XXX | n/a | XXX | XXX | XXX |
P/E | 27.1x | XXX | 31.8x | XXX | XXX | XXX |
EV/FCF | n/a | XXX | 30.0x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialStille's last 12 month revenue growth is 7%
Stille's revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.1M for the same period.
Stille's rule of 40 is 26% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Stille's rule of X is 38% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Stille and other 12K+ public compsLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Revenue Growth | 7% | XXX | 7% | XXX | XXX | XXX |
EBITDA Margin | 20% | XXX | 21% | XXX | XXX | XXX |
EBITDA Growth | 25% | XXX | 51% | XXX | XXX | XXX |
Rule of 40 | 26% | XXX | 28% | XXX | XXX | XXX |
Bessemer Rule of X | XXX | XXX | 38% | XXX | XXX | XXX |
Revenue per Employee | XXX | XXX | $0.4M | XXX | XXX | XXX |
Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
S&M Expenses to Revenue | XXX | XXX | 23% | XXX | XXX | XXX |
G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
Opex to Revenue | XXX | XXX | 32% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Ansell | XXX | XXX | XXX | XXX | XXX | XXX |
Polymed | XXX | XXX | XXX | XXX | XXX | XXX |
Farmaceutica Remedia | XXX | XXX | XXX | XXX | XXX | XXX |
Etropal | XXX | XXX | XXX | XXX | XXX | XXX |
Sopharma | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Stille acquired XXX companies to date.
Last acquisition by Stille was XXXXXXXX, XXXXX XXXXX XXXXXX . Stille acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free TrialWhen was Stille founded? | Stille was founded in 1841. |
Where is Stille headquartered? | Stille is headquartered in Sweden. |
How many employees does Stille have? | As of today, Stille has 147 employees. |
Is Stille publicy listed? | Yes, Stille is a public company listed on STO. |
What is the stock symbol of Stille? | Stille trades under STIL ticker. |
When did Stille go public? | Stille went public in 2005. |
Who are competitors of Stille? | Similar companies to Stille include e.g. Ansell, Polymed, Farmaceutica Remedia, Etropal. |
What is the current market cap of Stille? | Stille's current market cap is $195M |
What is the current revenue of Stille? | Stille's last 12 months revenue is $61.0M. |
What is the current revenue growth of Stille? | Stille revenue growth (NTM/LTM) is 7%. |
What is the current EV/Revenue multiple of Stille? | Current revenue multiple of Stille is 3.0x. |
Is Stille profitable? | Yes, Stille is EBITDA-positive (as of the last 12 months). |
What is the current EBITDA of Stille? | Stille's last 12 months EBITDA is $12.1M. |
What is Stille's EBITDA margin? | Stille's last 12 months EBITDA margin is 20%. |
What is the current EV/EBITDA multiple of Stille? | Current EBITDA multiple of Stille is 15.4x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.